Pengyuan Wang | Pancreatitis | Young Researcher Award

Mr. Pengyuan Wang | Pancreatitis | Young Researcher Award

Department of Gastroenterology, Changhai Hospital, Naval Medical University | China

Mr. Pengyuan Wang is an accomplished biomedical researcher and clinician specializing in gastroenterology and translational pharmacology. He obtained a Bachelor’s degree in Clinical Medicine, followed by a Ph.D. in Pharmacology, and further strengthened his academic foundation through postdoctoral training in Gastroenterology. He is currently affiliated with leading clinical and research centers in China, where he integrates clinical insight with mechanistic research to address complex gastrointestinal diseases. His professional experience bridges patient-oriented practice and laboratory-based investigation, enabling a strong bench-to-bedside research approach. Mr. Wang’s primary research interest focuses on the metabolic mechanisms underlying pancreatitis, with particular emphasis on identifying key molecular pathways involved in disease initiation and progression. In parallel, he is actively engaged in drug screening and pharmacological evaluation, aiming to discover and optimize therapeutic candidates for pancreatitis and related metabolic disorders. His work contributes to improving diagnostic strategies and advancing targeted treatments in gastroenterology. Recognized for his rigorous scientific approach and interdisciplinary expertise, he has received academic acknowledgment through competitive research training and scholarly contributions. Overall, Mr. Wang’s research continues to enhance the understanding of pancreatitis pathophysiology and supports the development of innovative therapeutic interventions with significant clinical relevance.

View ORCID Profile

Featured Publications

Xiang Wu | Medical Biomaterials | Research Excellence Award

Dr. Xiang Wu | Medical Biomaterials | Research Excellence Award

Ningbo University | China

Dr. Xiang Wu is a dedicated medical researcher and clinician currently serving at Ningbo Medical Center Li Huili Hospital, Health Science Center, Ningbo University, where he actively contributes to interdisciplinary biomedical research. With a strong academic foundation in medical sciences and biomaterials, his education and professional training have enabled him to bridge clinical needs with engineering-driven solutions. His experience spans hospital-based research and university-level scientific collaboration, focusing on translating laboratory innovations into practical medical applications. Dr. Wu’s primary research interests include functional hydrogels for tissue adhesion, hemostasis, postoperative repair, and advanced biomaterials such as bone and joint materials, adhesive systems, and Janus patches. In parallel, he investigates molecular regulatory mechanisms involving lncRNA and circRNA in cancers, particularly pancreatic and bladder cancer, highlighting his integrative approach that combines materials science with molecular medicine. Since 2020, his scholarly contributions have gained notable academic recognition, reflected in a strong citation record and h-index, underscoring the impact of his research on addressing clinical treatment challenges. His work aligns closely with modern translational medicine, emphasizing innovation, clinical relevance, and interdisciplinary collaboration. In conclusion, Dr. Wu represents a new generation of clinician-scientists whose research advances both biomedical materials and molecular oncology, contributing meaningfully to improved therapeutic strategies and future medical technologies.

Profiles: Orcid | Google Scholar

Featured Publications